Zhengye Biotechnology Holding Ltd SEC filings ZYBT
Zhengye Biotechnology Holding Ltd has 61 filings in SEC EDGAR's recent list, going back to Aug 4, 2023. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 6, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jun 4, 2026 | Jun 4, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 28, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 25, 2026 | Mar 24, 2026 |
| 6-K | Current report (foreign issuer) | Mar 2, 2026 | Feb 27, 2026 |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 23, 2026 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Jun 30, 2025 |
| 20-F | Annual report (foreign issuer) | Jul 3, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | May 23, 2025 | May 23, 2025 |
| NT 20-F | Notification of late filing | Apr 29, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 3, 2025 | Apr 2, 2025 |
| 6-K | Current report (foreign issuer) | Mar 6, 2025 | Mar 6, 2025 |
| 6-K | Current report (foreign issuer) | Jan 14, 2025 | Jan 14, 2025 |
| 6-K | Current report (foreign issuer) | Jan 8, 2025 | Jan 8, 2025 |
| 424B4 | Prospectus | Jan 7, 2025 | — |
| CERT | Filing | Jan 6, 2025 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| 8-A12B | For registration of certain classes | Dec 19, 2024 | — |
| POS AM | Post-effective amendment | Dec 9, 2024 | — |
| FWP | Free writing prospectus | Nov 21, 2024 | — |
| POS AM | Post-effective amendment | Nov 15, 2024 | — |
| EFFECT | Filing | Sep 30, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| F-1/A | Registration statement | Sep 18, 2024 | — |
| FWP | Free writing prospectus | Aug 27, 2024 | — |
| F-1/A | Registration statement | Aug 22, 2024 | — |
| FWP | Free writing prospectus | Jun 27, 2024 | — |
| FWP | Free writing prospectus | Jun 21, 2024 | — |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| F-1/A | Registration statement | Jun 14, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2024 | — |
| F-1/A | Registration statement | May 15, 2024 | — |
| CORRESP | Letter to the SEC | Jan 9, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Jan 9, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2023 | — |
| DRSLTR | Filing | Dec 14, 2023 | — |
| DRS/A | Filing | Dec 14, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2023 | — |
| DRSLTR | Filing | Nov 17, 2023 | — |
| DRS/A | Filing | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2023 | — |
| DRSLTR | Filing | Sep 28, 2023 | — |
| DRS/A | Filing | Sep 28, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2023 | — |
| DRS | Filing | Aug 4, 2023 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZYBT (Nasdaq)
- Incorporated in
- China
- Headquarters
- Jilin
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1975641
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.